113 related articles for article (PubMed ID: 115834)
1. Synergism between fosfomycin and nalidixic acid in vitro.
Ullmann U
J Antimicrob Chemother; 1979 Sep; 5(5):612-3. PubMed ID: 115834
[No Abstract] [Full Text] [Related]
2. [A study of the in vitro sensitivity of Enterobacteriaceae and Pseudomonas aeruginosa to 7 antimicrobial agents].
Lynch MB; Mimica I; Valenzuela MC; Vilches A; Abarca S
Rev Med Chil; 1972 Jan; 100(1):14-5. PubMed ID: 4622217
[No Abstract] [Full Text] [Related]
3. In vitro sensitivity pattern of gram negative pathogens to nalidixic acid.
Chitkara YK
Indian J Pathol Bacteriol; 1969 Oct; 12(4):162-8. PubMed ID: 4990210
[No Abstract] [Full Text] [Related]
4. In vitro investigations on the action fosfomycin alone and in combination with other antibiotics on Pseudomonas aeruginosa and Serratia marcescens.
Ullmann U; Lindemann B
Arzneimittelforschung; 1980; 30(8):1247-9. PubMed ID: 6776966
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of fosfomycin and carbapenems against carbapenem-resistant Pseudomonas aeruginosa clinical isolates.
Kunakonvichaya B; Thirapanmethee K; Khuntayaporn P; Montakantikul P; Chomnawang MT
Int J Antimicrob Agents; 2015 May; 45(5):556-7. PubMed ID: 25724628
[No Abstract] [Full Text] [Related]
6. Bactericidal effect of combinations of nalidixic acid and various antibiotics on Enterobacteriaceae.
Michel J; Luboshitzky R; Sacks T
Antimicrob Agents Chemother; 1973 Sep; 4(3):201-4. PubMed ID: 4758830
[TBL] [Abstract][Full Text] [Related]
7. [Sensitivity of clinical isolates of several enterobacteriaceae, pseudomonas aeruginosa, staphylococcus aureus and streptococcus faecalis to antibiotics. Results of a supraregional collaborative study of the "work-group on resistance" of the Paul Ehrlich Society for Chemotherapy (author's transl)].
Paul-Ehrlich-Gesellschaft
Infection; 1978; 6(1):35-44. PubMed ID: 415984
[No Abstract] [Full Text] [Related]
8. [The role of the culture medium in the sensitivity of Gram-negative stocks and their resistant mutants to fosfomycin. The influence of glucose-6-phosphate].
Drugeon H; Courtieu AL
Minerva Med; 1978 Dec; 69(59):4055-60. PubMed ID: 105326
[No Abstract] [Full Text] [Related]
9. Effect of nalidixic acid on the morphology and protein expression of Pseudomonas aeruginosa.
Al Bahry S; Sivakumar N; Al-Khambashi M
Asian Pac J Trop Med; 2012 Apr; 5(4):265-9. PubMed ID: 22449516
[TBL] [Abstract][Full Text] [Related]
10. Fosfomycin and plasmidic resistance.
Baquero F; López-Brea M; Valls A; Cañedo T
Chemotherapy; 1977; 23 Suppl 1():133-40. PubMed ID: 318973
[TBL] [Abstract][Full Text] [Related]
11. [Reevaluation of current antimicrobials. Fosfomycin sodium/calcium].
Hayashi I; Hasegawa H
Jpn J Antibiot; 1994 Jul; 47(7):861-8. PubMed ID: 7933518
[No Abstract] [Full Text] [Related]
12. [Susceptibility testing with fosfomycin in an agar diffusion test on Mueller-Hinton agar].
Grimm H; Haag R
Immun Infekt; 1982 Jul; 10(4):159-63. PubMed ID: 6813250
[TBL] [Abstract][Full Text] [Related]
13. [Antibacterial effect of N-formimidoyl-thienamycin in combination with amikacin, cefoxitin and fosfomycin on K. pneumoniae and P. aeruginosa].
Schröter G; Schrettenbrunner A
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Dec; 253(3):355-7. PubMed ID: 6820589
[No Abstract] [Full Text] [Related]
14. Antimicrobial activity of fosfomycin against multidrug-resistant Pseudomonas aeruginosa in vitro.
Kobayashi Y; Sumitani Y; Sugita K; Aikawa N
Int J Antimicrob Agents; 2007 Dec; 30(6):563-4. PubMed ID: 17900870
[No Abstract] [Full Text] [Related]
15. Evolution of bacterial sensitivity to fosfomycin in the Cindad Sanitaria 'Francisco Franco' in Barcelona.
Crespo E; Roca de Viñals JA
Chemotherapy; 1977; 23 Suppl 1():112-6. PubMed ID: 401716
[TBL] [Abstract][Full Text] [Related]
16. [Sensitivity of Pseudomonas aeruginosa strains isolated from pathological fluids to nalidixic acid and some antibacterial agents].
Vaszary I; Gláz E
Orv Hetil; 1965 Aug; 106(34):1595-8. PubMed ID: 4953226
[No Abstract] [Full Text] [Related]
17. In vitro activity of fosfomycin in combination with colistin against clinical isolates of carbapenem-resistant Pseudomas aeruginosa.
Di X; Wang R; Liu B; Zhang X; Ni W; Wang J; Liang B; Cai Y; Liu Y
J Antibiot (Tokyo); 2015 Sep; 68(9):551-5. PubMed ID: 25805069
[TBL] [Abstract][Full Text] [Related]
18. In vitro synergism of nalidixic acid with other broad spectrum antibiotics.
Piccolomini R; Cellini L; Allocati N; Ravagnan G
Chemioterapia; 1984 Apr; 3(2):103-7. PubMed ID: 6532536
[TBL] [Abstract][Full Text] [Related]
19. [Effects of erythromycin and fosfomycin on Pseudomonas aeruginosa biofilm in vitro].
Xu Z; Liu F; Wang X
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Jun; 24(6):342-4. PubMed ID: 11802985
[TBL] [Abstract][Full Text] [Related]
20. Use of Calgary and Microfluidic BioFlux Systems To Test the Activity of Fosfomycin and Tobramycin Alone and in Combination against Cystic Fibrosis Pseudomonas aeruginosa Biofilms.
Díez-Aguilar M; Morosini MI; Köksal E; Oliver A; Ekkelenkamp M; Cantón R
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29084746
[No Abstract] [Full Text] [Related]
[Next] [New Search]
